| For: | Imbrizi M, Azevedo MFC, Baima JP, Queiroz NSF, Parra RS, Ferreira SDC, Sassaki LY, Chebli JMF. Positioning and sequencing of advanced therapies in inflammatory bowel disease: A guide for clinical practice. World J Gastroenterol 2025; 31(29): 107745 [PMID: 40809925 DOI: 10.3748/wjg.v31.i29.107745] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v31/i29/107745.htm |
| Number | Citing Articles |
| 1 |
Ying Zhang, Qin Zhao, Jingcheng Miao, Jianjun Tu, Pengfei Wang, Anquan Li, Jun Li. Dynamic changes in serum gelsolin combined with clinical parameters to construct a predictive model for mucosal healing in inflammatory bowel disease: A prospective cohort study. Medicine 2026; 105(20) doi: 10.1097/MD.0000000000048832
|
| 2 |
Ahmed Quraish, Ro’ya Khanfar, Karmil Kharouf, Sami Salous, Dala Quraish, Qusay Abdoh. Disability among Palestinian patients with inflammatory bowel disease: evaluation using the IBD Disk and identification of associated factors. Crohn’s & Colitis 360 2026; 8(3) doi: 10.1093/crocol/otag079
|
| 3 |
Yiwen Sun, Jing Lv, Xiangyu Meng, Yanqiu Sun, Hualin Fu, Wei Xu, Zhiheng Du. Arctic Fox-Derived Lactiplantibacillus plantarum J3 Alleviates Colitis in Mice in Association with Strengthening of the Intestinal Barrier and Reshaping of the Intestinal Flora. Life 2026; 16(8) doi: 10.3390/life16081355
|
| 4 |
Natália de Castro Borges, Hélio Paulo de Matos Neto, Lawani Rigopoulos, Maria Paula Ribeiro Dantas Bezerra, Maria Carolina Dias Rego, Luísa Leite Barros. Disseminated Tuberculosis With Placental Involvement in a Crohn’s Disease Patient Treated With Combination Therapy. Gastro Hep Advances 2026; 5(8) doi: 10.1016/j.gastha.2026.100998
|
| 5 |
Tetsuya Koyama, Tatsunori Seki. Safety, Pharmacokinetics, Food effect, and Pharmacodynamics of AJM347, a Selective α4β7 Integrin Antagonist: A First‐in‐Human Single‐ and Multiple‐Ascending Dose Study in Healthy Male Volunteers. The Journal of Clinical Pharmacology 2026; 66(8) doi: 10.1002/jcph.70260
|
| 6 |
Iago Rodríguez-Lago, Fernando Muñoz Núñez, Alfredo J. Lucendo, Alfonso De Lossada Juste, Ana Cabez, Alberto de la Cuadra-Grande, Itziar Oyagüez, Emilio Monte-Boquet. Cost-Effectiveness Analysis of Etrasimod Compared With Biologic Therapies for the Treatment of Patients with Moderately-to-Severely Active Ulcerative Colitis in Spain. PharmacoEconomics - Open 2026; 10(1) doi: 10.1007/s41669-025-00619-6
|
| 7 |
Jonathan Soldera, Maria Antonia Selbach Pertile, Leticia Nodari Carobin, Daniel Jun Funatsu Brambilla, Eduardo Brambilla. Beyond class switching in multi-refractory inflammatory bowel disease: Nine case reports and review of literature. World Journal of Gastrointestinal Pharmacology and Therapeutics 2026; 17(3): 120771 doi: 10.4292/wjgpt.120771
|
| 8 |
Joana Camões Neves, Dalila Costa, Margarida Cristiano, Francisco Portela, Ana Rita Fernandes, Samuel Fernandes, Nuno Gonçalves, João Pedro Paulo, Margarida Portugal, Madalina Gututui, Daniela Fernandes, Catarina Costa, Ana Margarida Madureira, Jorge Marques, Patrícia Vaz Conde, José Damasceno, Andreia Guimarães, Ana Rebelo, Margarida Gonçalves, João Soares, Sofia Silva Mendes, Bruno Arroja, Raquel Gonçalves, Tiago Leal. Superior Effectiveness of Upadacitinib Over Tofacitinib and Ustekinumab in Bio-Exposed Ulcerative Colitis: The TRIDENT-UC Study. Clinical Gastroenterology and Hepatology 2026; doi: 10.1016/j.cgh.2026.07.020
|